{"created":"2021-03-01T06:32:39.566773+00:00","id":24689,"links":{},"metadata":{"_buckets":{"deposit":"d8723f17-f311-4793-9d15-4dadae122396"},"_deposit":{"id":"24689","owners":[],"pid":{"revision_id":0,"type":"depid","value":"24689"},"status":"published"},"_oai":{"id":"oai:nagoya.repo.nii.ac.jp:00024689"},"item_9_biblio_info_6":{"attribute_name":"\u66f8\u8a8c\u60c5\u5831","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2017-08","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"338","bibliographicPageStart":"331","bibliographicVolumeNumber":"79","bibliographic_titles":[{"bibliographic_title":"Nagoya Journal of Medical Science"}]}]},"item_9_description_4":{"attribute_name":"\u6284\u9332","attribute_value_mlt":[{"subitem_description":"The purpose of this study was to evaluate the clinical outcomes of radiotherapy for patients with T1/T2 glottic carcinoma. Patients with T1/T2 glottic carcinoma histopathologically diagnosed with squamous cell carcinoma and treated at our hospital between 2007 and 2015 were analyzed retrospectively. Our strategy for T1/T2 glottic carcinoma was as follows: radiotherapy alone with 2.25 Gy per fraction to a total of 25\u201328 fractions for patients with non-bulky T1 glottic carcinoma; concurrent chemoradiotherapy with oral S-1 and radiotherapy with 2 Gy per fraction to a total of 30 fractions for patients with T1 bulky/T2 favorable glottic carcinoma; or chemoradiotherapy with high-dose cisplatin and radiotherapy with 2 Gy per fraction to a total of 35 fractions for T2 unfavorable glottic carcinoma. Forty-eight patients were eligible. The median follow-up period among surviving patients was 38 months (range, 11\u2013107). The disease was T1a in 23%, T1b in 13%, and T2 in 65% of patients. The 3-year local control rate in all patients, T1a, T1b, and T2 was 96.7%, 100%, 100%, and 96.0%, respectively. Of the 46 patients, one with T2 glottic carcinoma developed recurrent disease at the primary site, and one with T2 glottic carcinoma had lymph node recurrences in the neck. Acute Grade 3 dermatitis occurred in 8 (17%) patients and late Grade 2 hypothyroidism occurred in 2 (4%) patients. This retrospective study shows that our optimized treatment strategy of radiotherapy depending on the stage of early glottic carcinoma is not only effective but also well-tolerated.","subitem_description_type":"Abstract"}]},"item_9_identifier_60":{"attribute_name":"URI","attribute_value_mlt":[{"subitem_identifier_type":"URI","subitem_identifier_uri":"http://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/793.html"},{"subitem_identifier_type":"HDL","subitem_identifier_uri":"http://hdl.handle.net/2237/26911"}]},"item_9_identifier_registration":{"attribute_name":"ID\u767b\u9332","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.18999/nagjms.79.3.331","subitem_identifier_reg_type":"JaLC"}]},"item_9_publisher_32":{"attribute_name":"\u51fa\u7248\u8005","attribute_value_mlt":[{"subitem_publisher":"Nagoya University Graduate School of Medicine, School of Medicine"}]},"item_9_select_15":{"attribute_name":"\u8457\u8005\u7248\u30d5\u30e9\u30b0","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_9_source_id_7":{"attribute_name":"ISSN\uff08print\uff09","attribute_value_mlt":[{"subitem_source_identifier":"0027-7622","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"\u8457\u8005","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Kimura, Kana"}],"nameIdentifiers":[{"nameIdentifier":"73222","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Itoh, Yoshiyuki"}],"nameIdentifiers":[{"nameIdentifier":"73223","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Okada, Tohru"}],"nameIdentifiers":[{"nameIdentifier":"73224","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kubota, Seiji"}],"nameIdentifiers":[{"nameIdentifier":"73225","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kawamura, Mariko"}],"nameIdentifiers":[{"nameIdentifier":"73226","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Nakahara, Rie"}],"nameIdentifiers":[{"nameIdentifier":"73227","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Oie, Yumi"}],"nameIdentifiers":[{"nameIdentifier":"73228","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kozai, Yuka"}],"nameIdentifiers":[{"nameIdentifier":"73229","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Takase, Yuuki"}],"nameIdentifiers":[{"nameIdentifier":"73230","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Tsuzuki, Hidenori"}],"nameIdentifiers":[{"nameIdentifier":"73231","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Nishio, Naoki"}],"nameIdentifiers":[{"nameIdentifier":"73232","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Hiramatsu, Mariko"}],"nameIdentifiers":[{"nameIdentifier":"73233","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Fujimoto, Yasushi"}],"nameIdentifiers":[{"nameIdentifier":"73234","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Mizutani, Takefumi"}],"nameIdentifiers":[{"nameIdentifier":"73235","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Naganawa, Shinji"}],"nameIdentifiers":[{"nameIdentifier":"73236","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"\u30d5\u30a1\u30a4\u30eb\u60c5\u5831","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2018-02-22"}],"displaytype":"detail","filename":"06_Kimura.pdf","filesize":[{"value":"293.5 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"06_Kimura.pdf","url":"https://nagoya.repo.nii.ac.jp/record/24689/files/06_Kimura.pdf"},"version_id":"aa322767-ca8b-4fba-80c0-d747a9e2de9b"}]},"item_keyword":{"attribute_name":"\u30ad\u30fc\u30ef\u30fc\u30c9","attribute_value_mlt":[{"subitem_subject":"early glottic cancer","subitem_subject_scheme":"Other"},{"subitem_subject":"radiotherapy","subitem_subject_scheme":"Other"},{"subitem_subject":"chemoradiotherapy","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"\u8a00\u8a9e","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"\u8cc7\u6e90\u30bf\u30a4\u30d7","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Optimized treatment strategy of radiotherapy for early glottic squamous cell carcinomas : An initial analysis","item_titles":{"attribute_name":"\u30bf\u30a4\u30c8\u30eb","attribute_value_mlt":[{"subitem_title":"Optimized treatment strategy of radiotherapy for early glottic squamous cell carcinomas : An initial analysis"}]},"item_type_id":"9","owner":"1","path":["499/508/509/2036"],"pubdate":{"attribute_name":"\u516c\u958b\u65e5","attribute_value":"2017-08-23"},"publish_date":"2017-08-23","publish_status":"0","recid":"24689","relation_version_is_last":true,"title":["Optimized treatment strategy of radiotherapy for early glottic squamous cell carcinomas : An initial analysis"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2021-03-01T13:56:27.304329+00:00"}